Multiline treatment combining apatinib with toptecan for platinum-resistant recurrent ovarian cancer patients: a report of three cases

The aim of this study was to observe the efficacy and safety of apatinib combined with toptecan therapy in the multiline treatment of platinum-resistant recurrent ovarian cancer patients. The clinical records of three patients with platinum-resistant recurrent ovarian cancer treated with apatinib co...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yuan, Zhang, Juan, Geng, Haiyun, Qin, Shukui, Hua, Haiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898585/
https://www.ncbi.nlm.nih.gov/pubmed/29670374
http://dx.doi.org/10.2147/OTT.S158141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898585/
https://www.ncbi.nlm.nih.gov/pubmed/29670374
http://dx.doi.org/10.2147/OTT.S158141

Ejemplares similares